???global.info.a_carregar???
T.R. Rosenstock is a Collaborator Professor at University of Sao Paulo (Brazil) and a Principal Scientist at Sygnature Discovery (UK). T.Rosenstock group is focused in investigating the relationship between transcription deregulation and mitochondrial dysfunction in different models of neurodegenerative and neuropsychiatric disorders such as Amyotrophic Lateral Sclerosis and Schizophrenia. Currently, T.Rosenstock is investigating mitochondrial degradation in several neurodegenerative disease models using iPSCs and hESCells as platforms. From 2014 to 2020, TR Rosenstock was an Associate Professor at Department of Physiological Science at Santa Casa de São Paulo School of Medical Sciences (FCMSCSP) (São Paulo, Brazil). T Rosenstock received in 2019, the Rutherford Fellowship (UK), and in 2017 and 2018, the Brazil Visiting Fellowship from University of Birmingham (UK). Between 2017-2018, T Rosenstock was Vice-Coordinator of Postgraduate Program in Health Science at FCMSCSP; today she is part of the Board Member of the Program. From 2015, T Rosenstock is a member of the International Relations Office and President of the Internal Biosecurity Committee. From 2008 to 2014, she was a Post-Doc fellow at Center for Neuroscience and Cell Biology (Portugal), and she continues to collaborate with research groups in the institution resulting in recent publications. The collaboration includes visits to CNC as invited researcher and exchanging graduate students for internships and developing lab work. She was also PI from the FCT project EXPL/BIM-MEC/2220/2013. In 2012, TR got a fellowship to stay at Dept. Biological Engineering at MIT (Boston/Cambridge, USA), in 2007 she received an exchange fellowship to develop part of her PhD work at University of Rome TorVergata (Italy), and in 2002 a short-stay fellowship from Howard Hugues Medical Institution. Group website: me-neuro.com; Email: tatirosenstock@usp.br; t.rosenstock@bham.ac.uk.
Ler resumo completo ↓
Identificação

Identificação pessoal

Nome completo
Tatiana Rosado Rosenstock

Nomes de citação

  • Rosenstock, Tatiana
  • Rosenstock, T.R.

Identificadores de autor

Ciência ID
5115-63E7-F6D5
ORCID iD
0000-0003-1153-7412
Google Scholar ID
https://scholar.google.com/citations?hl=pt-BR&user=cDOQclUAAAAJ
Researcher Id
N-1949-2013
Scopus Author Id
6602375830

Endereços de correio eletrónico

  • tatirosenstock@gmail.com (Profissional)
  • tatirosenstock@gmail.com (Profissional)
  • t.rosenstock@sygnaturediscovery.com (Profissional)

Websites

Domínios de atuação

  • Ciências Médicas e da Saúde - Medicina Básica

Idiomas

Idioma Conversação Leitura Escrita Compreensão Peer-review
Português (Idioma materno)
Inglês Utilizador proficiente (C1) Utilizador proficiente (C1) Utilizador proficiente (C1) Utilizador proficiente (C1) Utilizador proficiente (C1)
Italiano Utilizador independente (B1) Utilizador independente (B1) Utilizador independente (B1) Utilizador independente (B1)
Espanhol; Castelhano Utilizador independente (B1) Utilizador independente (B1) Utilizador independente (B1) Utilizador independente (B1)
Formação
Grau Classificação
2014/02
Concluído
 Biomedicina (Bachelor)
Universidade Federal de São Paulo, São Paulo/ SP, BRasil, Brasil
"Doença de Huntington: aspectos celulares" (TESE/DISSERTAÇÃO)
 sem classificação
2008
Concluído
 Doutor em Ciências pelo Programa de Pós-Graduação em Farmacologia (Doktor (PhD))
Universidade Federal de São Paulo, São Paulo/ SP, BRasil, Brasil
"Estudo dos mecanismos celulares e moleculares envolvidos no processo neurodegenerativo da Doença de Huntington" (TESE/DISSERTAÇÃO)
 sem classificação
2004
Concluído
 Mestre em Ciências pelo Programa de Pós-Graduação em Farmacologia (Master Universitario)
Universidade Federal de São Paulo, São Paulo/ SP, BRasil, Brasil
"Estudo da sinalização da morte celular e de alterações comportamentais em modelos animais da Doença neurodegenerativa de Huntington" (TESE/DISSERTAÇÃO)
 sem classificação
Percurso profissional

Ciência

Categoria Profissional
Instituição de acolhimento 		Empregador
2021/12/06 - Atual Investigador principal (carreira) (Investigação) Sygnature Discovery Ltd, Reino Unido
2021/01/01 - 2021/11/01 Investigador Contratado (Investigação) University of Birmingham, Reino Unido
2019/01 - 2019/03 Investigador visitante (Investigação) University of Birmingham Institute of Cancer and Genomic Sciences, Reino Unido
2018/06 - 2018/08 Investigador visitante (Investigação) University of Birmingham Institute of Cancer and Genomic Sciences, Reino Unido
2017/06 - 2017/08 Investigador visitante (Investigação) University of Birmingham Institute of Cancer and Genomic Sciences, Reino Unido

Docência no Ensino Superior

Categoria Profissional
Instituição de acolhimento 		Empregador
2016/06 - 2020/05/26 Professor Associado (Docente Universitário) Faculdade de Ciências Médicas da Santa Casa de São Paulo, Brasil
2014/11 - 2016/05 Professor Auxiliar (Docente Universitário) Faculdade de Ciências Médicas da Santa Casa de São Paulo, Brasil

Outros

Categoria Profissional
Instituição de acolhimento 		Empregador
2008/06/20 - 2014/02/14 Pós-Doutoramento Centro de Neurociências e Biologia Celular (CNBC), Faculdade de Medicina, Universidade de Coimbra, Coimbra, Portugal, Portugal
2012/04/06 - 2012/07/06 PhD Affiliate at the Dept. of Biological Engineering Massachusetts Institute of Technology Massachusetts (MIT) in the Lab of Prof. Ernest Fraenkel: “Evaluation of transcription factors by modification Massachusetts Institute of Technology Massachusetts (MIT) – USA, Estados Unidos
2004/03/08 - 2008/06/18 Doutoranda Universidade Federal de São Paulo, São Paulo/ SP, BRasil, Brasil
2007/03/06 - 2007/11/15 Estágio de Doutoramento Univeristy of Rome Tor Vergata, Itália
2002/02/04 - 2004/03/01 Mestranda Universidade Federal de São Paulo, São Paulo/ SP, BRasil, Brasil
1998/02/09 - 2001/12/14 Estudante de graduação (Biomedicina) Universidade Federal de São Paulo, São Paulo/ SP, BRasil, Brasil
Projetos

Bolsa

Designação Financiadores
2016/04 - 2021/04 The role of lysine(K)-deacetylases on mitochondrial disorders’s neuroprotection: Perspectives of epigenetic therapy for Amyotrophic Lateral Sclerosis and Schizophrenia.
2015/020411
 FAPESP - Fundação de Amparo à Pesquisa do Estado De São Paulo
2018 - 2020 Modulation of autophagy and mitochondrial degradation by lysine deacetylation after superexpression an inhibition of genes related to Amyotrophic Lateral Sclerosis
2018-2020
 Fundação de Amparo a Pesquisa (FAP) da FCMSCSP
2018 - 2020 Mitochondrial metabolism and its relation to neurogenesis in an animal model of Schizophrenia with aging
2018/08399-3
 Fundação de Amparo à Pesquisa do Estado de São Paulo
2014 - 2015 Role of sirtuin 3 on mitochondrial function and deacetylation of mitochondrial targets: relevance for Huntington’s disease.
EXPL/BIM-MEC/2220/2013
 Fundação para a Ciência e a Tecnologia, I.P. & COMPETE 2020

Projeto

Designação Financiadores
2018 - 2018 III Workshop internacional Implication of metabolic and epigenetic modifications for neuroprotection: relevance to translational research
processo 2017/26394-6
 Fundação de Amparo à Pesquisa do Estado de São Paulo
Produções

Publicações

Artigo em revista
  1. "Autophagy Dysfunction as a Phenotypic Readout in hiPSC-Derived Neuronal Cell Models of Neurodegenerative Diseases.". Methods in molecular biology (Clifton, N.J.) (2021): https://doi.org/10.1007/7651_2021_420.
    10.1007/7651_2021_420
  2. Thiago Garcia Varga; Juan Guilherme de Toledo Simões; Amanda Siena; Elisandra Henrique; Regina Cláudia Barbosa da Silva; Vinicius dos Santos Bioni; Aline Camargo Ramos; Tatiana Rosado Rosenstock. "Haloperidol rescues the schizophrenia-like phenotype in adulthood after rotenone administration in neonatal rats". Psychopharmacology (2021): https://doi.org/10.1007/s00213-021-05880-1.
    10.1007/s00213-021-05880-1
  3. "New Avenues for the Treatment of Huntington's Disease.". International journal of molecular sciences (2021): https://europepmc.org/articles/PMC8394361.
    10.3390/ijms22168363
  4. Amanda Siena; Jéssica Mayumi Camargo Yuzawa; Aline Camargo Ramos; Elisandra Henrique; Mariana Dutra Brito; Mariana Bendlin Calvazara; Tatiana Rosado Rosenstock. "Neonatal Rotenone Administration Induces Psychiatric Disorder-Like Behavior and Changes in Mitochondrial Biogenesis and Synaptic Proteins in Adulthood". Molecular Neurobiology (2021): https://doi.org/10.1007/s12035-021-02317-w.
    10.1007/s12035-021-02317-w
  5. Rosenstock, T.R.. "Increased acute blood flow induced by the aqueous extract of Euterpe oleracea Mart. fruit pulp in rats in vivo is not related to the direct activation of endothelial cells.". Journal of ethnopharmacology (2021): https://doi.org/10.1016/j.jep.2021.113885.
    10.1016/j.jep.2021.113885
  6. Rosenstock, T.R.. "Oxygen Consumption Evaluation: An Important Indicator of Metabolic State, Cellular Function, and Cell Fate Along Neural Deregulation.". Methods in molecular biology (Clifton, N.J.) (2021): https://doi.org/10.1007/978-1-0716-1091-6_15.
    10.1007/978-1-0716-1091-6_15
  7. Beatriz Grisolia Araujo; Luiz Felipe Souza e Silva; Jorge Luiz de Barros Torresi; Amanda Siena; Berenice Cataldo Oliveira Valerio; Mariana Dutra Brito; Tatiana Rosado Rosenstock. "Decreased Mitochondrial Function, Biogenesis, and Degradation in Peripheral Blood Mononuclear Cells from Amyotrophic Lateral Sclerosis Patients as a Potential Tool for Biomarker Research". Molecular Neurobiology (2020): https://doi.org/10.1007/s12035-020-02059-1.
    10.1007/s12035-020-02059-1
  8. Rosenstock, T.R.. "Mitochondrial SIRT3 confers neuroprotection in Huntington's disease by regulation of oxidative challenges and mitochondrial dynamics.". Free radical biology & medicine (2020): https://doi.org/10.1016/j.freeradbiomed.2020.11.031.
    10.1016/j.freeradbiomed.2020.11.031
  9. Rosenstock, T.R.. "Mitochondrial Dysfunction, Neurogenesis, and Epigenetics: Putative Implications for Amyotrophic Lateral Sclerosis Neurodegeneration and Treatment.". Frontiers in neuroscience (2020): https://europepmc.org/articles/PMC7373761.
    10.3389/fnins.2020.00679
  10. Rosenstock, T.R.. "Human Induced Pluripotent Stem Cell Models of Neurodegenerative Disorders for Studying the Biomedical Implications of Autophagy". Journal of Molecular Biology (2020): http://dx.doi.org/10.1016/j.jmb.2020.01.024.
    10.1016/j.jmb.2020.01.024
  11. Luiz Felipe Souza e Silva; Mariana Dutra Brito; Jéssica Mayumi Camargo Yuzawa; Tatiana Rosado Rosenstock. "Mitochondrial Dysfunction and Changes in High-Energy Compounds in Different Cellular Models Associated to Hypoxia: Implication to Schizophrenia". Scientific Reports (2019): https://doi.org/10.1038/s41598-019-53605-4.
    10.1038/s41598-019-53605-4
  12. Rosenstock, T.R.. "Metabolic Alteration and Amyotrophic Lateral Sclerosis Outcome: A Systematic Review.". Frontiers in neurology (2019): https://europepmc.org/articles/PMC6879457.
    10.3389/fneur.2019.01205
  13. Rosenstock, T.R.. "Chemical Screening Approaches Enabling Drug Discovery of Autophagy Modulators for Biomedical Applications in Human Diseases.". Frontiers in cell and developmental biology (2019): https://europepmc.org/articles/PMC6436197.
    10.3389/fcell.2019.00038
  14. Rosenstock, Tatiana. "In Vitro Screening Platforms for Identifying Autophagy Modulators in Mammalian Cells". Methods Mol Biol (2019):
    10.1007/978-1-4939-8873-0_26
  15. Rosenstock, Tatiana. "Dysregulation of autophagy as a common mechanism in lysosomal storage diseases". Essays in Biochemistry (2017):
    10.1042/EBC20170055
  16. Luana Naia; Teresa Cunha-Oliveira; Joana Rodrigues; Tatiana R. Rosenstock; Ana Oliveira; Márcio Ribeiro; Catarina Carmo; et al. "Histone Deacetylase Inhibitors Protect Against Pyruvate Dehydrogenase Dysfunction in Huntington's Disease". The Journal of Neuroscience 37 10 (2017): 2776-2794. https://doi.org/10.1523%2Fjneurosci.2006-14.2016.
    10.1523/JNEUROSCI.2006-14.2016
  17. Rosenstock, Tatiana. "Selfish brain and selfish immune system interplay: A theoretical framework for metabolic comorbidities of mood disorders.". (2017):
    10.1016/j.neubiorev.2016.11.010
  18. Rosenstock, Tatiana. "Gene Expression Control by Glucocorticoid Receptors during Innate Immune Responses.". Front Endocrinol (2016): http://journal.frontiersin.org/article/10.3389/fendo.2016.00031/full.
    10.3389/fendo.2016.00031
  19. Rosenstock, Tatiana. "CD36 is expressed in a defined subpopulation of neurons in the olfactory epithelium". Scientific Reports (2016): http://www.nature.com/articles/srep25507.
    10.1038/srep25507
  20. Rosenstock, Tatiana. "Insulin and IGF-1 regularize energy metabolites in neural cells expressing full-length mutant huntingtin.". Neuropeptides. (2016): http://linkinghub.elsevier.com/retrieve/pii/S0143-4179(16)00017-2.
    10.1016/j.npep.2016.01.009
  21. Rosenstock, Tatiana. "Comparative Mitochondrial-Based Protective Effects of Resveratrol and Nicotinamide in Huntington’s Disease Models". Mol Neurobiol (2016): http://link.springer.com/article/10.1007/s12035-016-0048-3?view=classic.
    10.1007/s12035-016-0048-3
  22. Naia, Luana; Ferreira, I. Luísa; Cunha-Oliveira, Teresa; Duarte, Ana I.; Ribeiro, Márcio; Rosenstock, Tatiana R.; Laço, Mário N.; et al. "Activation of IGF-1 and Insulin Signaling Pathways Ameliorate Mitochondrial Function and Energy Metabolism in Huntington’s Disease Human Lymphoblasts". Molecular Neurobiology (2015): http://hdl.handle.net/10316/41106.
    10.1007/s12035-014-8735-4
  23. Rosenstock, Tatiana. "Deficits of pyruvate dehydrogenase and mitochondrial dysfunction in Huntington's disease — role of histone deacetylase inhibitors". Biochimica et Biophysica Acta (2014):
    10.1016/j.bbabio.2014.05.003
  24. Rosenstock, TR; Ribeiro, Márcio; Rosenstock, Tatiana R.; Oliveira, Ana M.; Oliveira, Catarina R.; Rego, A. Cristina. "Insulin and IGF-1 improve mitochondrial function in a PI-3K/Akt-dependent manner and reduce mitochondrial generation of reactive oxygen species in Huntington's disease knock-in striatal cells". Free Radical Biology and Medicine (2014): http://www.sciencedirect.com/science/article/pii/S0891584914002755.
    10.1016/j.freeradbiomed.2014.06.023
  25. Brett, A.C.; Rosenstock, T.R.; Rego, A.C.. "Current therapeutic advances in patients and experimental models of Huntington's disease". Current Drug Targets 15 3 (2014): 313-334. http://www.scopus.com/inward/record.url?eid=2-s2.0-84896718561&partnerID=MN8TOARS.
    10.2174/1389450114666131124140704
  26. Ribeiro, M.; Rosenstock, T.R.; Cunha-Oliveira, T.; Ferreira, I.L.; Oliveira, C.R.; Rego, A.C.; Ribeiro, Márcio; et al. "Glutathione redox cycle dysregulation in Huntington's disease knock-in striatal cells". Free Radical Biology and Medicine 53 10 (2012): 1857-1867. http://www.scopus.com/inward/record.url?eid=2-s2.0-84867380632&partnerID=MN8TOARS.
    10.1016/j.freeradbiomed.2012.09.004
  27. Rosenstock, T.R.; De Brito, O.M.; Lombardi, V.; Louros, S.; Ribeiro, M.; Almeida, S.; Ferreira, I.L.; Oliveira, C.R.; Rego, A.C.. "FK506 ameliorates cell death features in Huntington's disease striatal cell models". Neurochemistry International 59 5 (2011): 600-609. http://www.scopus.com/inward/record.url?eid=2-s2.0-80052936684&partnerID=MN8TOARS.
    10.1016/j.neuint.2011.04.009
  28. Rosenstock, T.R.; Duarte, A.I.; Rego, A.C.. "Mitochondrial-associated metabolic changes and neurodegeneration in Huntington's disease - from clinical features to the bench". Current Drug Targets 11 10 (2010): 1218-1236. http://www.scopus.com/inward/record.url?eid=2-s2.0-77957993152&partnerID=MN8TOARS.
  29. Rosenstock, T.R.; Bertoncini, C.R.A.; Teles, A.V.; Hirata, H.; Fernandes, M.J.S.; Smaili, S.S.. "Glutamate-induced alterations in Ca2+ signaling are modulated by mitochondrial Ca2+ handling capacity in brain slices of R6/1 transgenic mice". European Journal of Neuroscience 32 1 (2010): 60-70. http://www.scopus.com/inward/record.url?eid=2-s2.0-77954403183&partnerID=MN8TOARS.
    10.1111/j.1460-9568.2010.07268.x
  30. Rosenstock, T.R.; Abílio, V.C.; Frussa-Filho, R.; Kiyomoto, B.H.; Smaili, S.S.. "Old mice present increased levels of succinate dehydrogenase activity and lower vulnerability to dyskinetic effects of 3-nitropropionic acid". Pharmacology Biochemistry and Behavior 91 3 (2009): 327-332. http://www.scopus.com/inward/record.url?eid=2-s2.0-57449108306&partnerID=MN8TOARS.
    10.1016/j.pbb.2008.08.011
  31. Smaili,Soraya; Hirata,Hanako; Ureshino,Rodrigo; Monteforte,Priscila T.; Morales,Ana P.; Muler,Mari L.; Terashima,Juliana; et al. "Calcium and cell death signaling in neurodegeneration and aging". Anais da Academia Brasileira de Ciencias 81 3 (2009): 467-475. http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0001-37652009000300011.
    http://dx.doi.org/10.1590/S0001-37652009000300011
  32. Smaili, Soraya S.; Rosenstock, Tatiana R.; Hsu, Yi-Te; KhosraviFar, R; Zakeri, Z; Lockshin, RA; Piacentini, M. "Evaluation of some cell death features by real time real space microscopy". Programmed Cell Death, General Principles For Studying Cell Death, Pt a 442 (2008): 27-50.
    10.1016/S0076-6879(08)01402-X
  33. Teles, A.V.F.F.; Rosenstock, T.R.; Okuno, C.S.; Lopes, G.S.; Bertoncini, C.R.A.; Smaili, S.S.. "Increase in bax expression and apoptosis are associated in Huntington's disease progression". Neuroscience Letters 438 1 (2008): 59-63. http://www.scopus.com/inward/record.url?eid=2-s2.0-43549102381&partnerID=MN8TOARS.
    10.1016/j.neulet.2008.03.062
  34. Carvalho, A.C.P.; Sharpe, J.; Rosenstock, T.R.; Teles, A.F.V.; Youle, R.J.; Smaili, S.S.. "Erratum: Bax affects intracellular Ca2+ stores and induces Ca2+ wave propagation (Cell Death and Differentiation (2004) vol. 11 (1265-1276) 10.1038/sj.cdd.4401508)". Cell Death and Differentiation 12 1 (2005): http://www.scopus.com/inward/record.url?eid=2-s2.0-11844269204&partnerID=MN8TOARS.
    10.1038/sj.cdd.4401550
  35. Carvalho, A.C.P.; Sharpe, J.; Rosenstock, T.R.; Teles, A.F.V.; Kowaltowski, A.J.; Youle, R.J.; Smaili, S.S.. "Bax affects intracellular Ca2+ stores and induces Ca2+ wave propagation". Cell Death and Differentiation 11 12 (2004): 1265-1276. http://www.scopus.com/inward/record.url?eid=2-s2.0-9944263437&partnerID=MN8TOARS.
    10.1038/sj.cdd.4401508
  36. Universidade Federal de São Paulo (UNIFESP); Rosenstock, T.R.; Carvalho, A.C.P.; Jurkiewicz, A.; Frussa-Filho, R.; Smaili, S.S.. "Mitochondrial calcium, oxidative stress and apoptosis in a neurodegenerative disease model induced by 3-nitropropionic acid". Journal of Neurochemistry 88 5 (2004): 1220-1228. http://repositorio.unifesp.br/handle/11600/27635.
    http://dx.doi.org/10.1046/j.1471-4159.2003.02250.x
  37. Smaili, S.S.; Hsu, T.-T.; Carvalho, A.C.P.; Rosenstock, T.R.; Sharpe, J.C.; Youle, R.J.. "Mitochondria, calcium and pro-apoptotic proteins as mediators in cell death signaling". Brazilian Journal of Medical and Biological Research 36 2 (2003): 183-190. http://www.scopus.com/inward/record.url?eid=2-s2.0-0344838596&partnerID=MN8TOARS.
Tese / Dissertação
  1. Natália Mendes Schöwe. "Avaliação de mecanismos de prevenção e tratamento com microdose de lítio e associação com rivastigmina em modelo de neurodegeneração por infusão crônica de ß-amiloide.". Doutoramento, 2018. http://www.teses.usp.br/teses/disponiveis/42/42136/tde-20022019-154900/.
  2. Marina Minto Cararo. "Sinalização via receptor N-Metil-D-Aspartato e modulação da Na+, K+-ATPase em camundongos hipomórficos para klotho: efeitos em hipocampo e cerebelo.". Mestrado, 2017. http://www.teses.usp.br/teses/disponiveis/42/42136/tde-14072017-092741/.
  3. Beatriz Sakashita Logatto de Souza. "Efeitos bioquímicos e comportamentais do pré-tratamento com agonista inverso CB1 na sinalização inflamatória desencadeada por LPS em camundongos.". Mestrado, 2017. http://www.teses.usp.br/teses/disponiveis/42/42136/tde-02022018-142433/.
  4. Mariana Furio Franco Bernardes. "Avaliação da citotoxicidade, genotoxicidade e mutagenicidade dos herbicidas tebutiurom e trifluralina e de seus efeitos na expressão de genes de resposta ao estresse celular". Doutoramento, 2016. http://www.teses.usp.br/teses/disponiveis/60/60134/tde-07072016-151441/.
  5. Rosenstock, Tatiana Rosado [UNIFESP]. "Estudo dos mecanismos celulares e moleculares envolvidos no processo neurodegenerativo da Doença de Huntington". Doutoramento, 2008. http://repositorio.unifesp.br/handle/11600/9573.
Distinções

Prémio

2020 2º place; XXXIX Congresso Médico Universitário da FMUSP do Departamento Científico da Faculdade de Medicina da Universidade de São Paulo
2019 2019 | POSTER SECTION – PRIZE WINNER
2019 Winner - 36º Congresso Médico Acadêmico da Faculdade de Ciências Médicas da Santa Casa de São Paulo
2018 2nd best poster presented at III WORKSHOP “Implication of metabolic and epigenetic modifications for neuroprotection: relevance to translational research”
2018 3rd best poster presented at III WORKSHOP “Implication of metabolic and epigenetic modifications for neuroprotection: relevance to translational research”
Faculdade de Ciências Médicas da Santa Casa de São Paulo, Brasil
2018 First best presentation - 35º Congresso Médico Acadêmico da Santa Casa De São Paulo (CoMASC) e Jornada de Prêmios Manoel de Abreu e Emílio Athié
Faculdade de Ciências Médicas da Santa Casa de São Paulo, Brasil
2017 Best poster presentation at Brazilian Socity for Neuroscience (SBNec)

Outra distinção

2019 Rutherford Fellow Award 2018-2019
University of Birmingham College of Medical and Dental Sciences, Reino Unido
2018 Brazil Visiting Fellow Award 2018
University of Birmingham College of Medical and Dental Sciences, Reino Unido
2017 Brazil Visiting Fellow Award 2017
University of Birmingham College of Medical and Dental Sciences, Reino Unido
2012 Melhor pôster
2012 Melhor pôster
2009 Melhor pôster do curso
2005 Melhor pôster da seção
2004 Prêmio José Ribeiro do Vale
2004 Melhor pôster da seção
2002 Melhor pôster da seção